Get started
Author

Lisa Tan

Therapy-Induced Evolution of Human Lung Cancer Revealed by Single-Cell RNA Sequencing
2020 · Ashley Maynard, Caroline E. McCoach, et al. · Cell · 694
PDF
The role of APOBEC3B in lung tumor evolution and targeted cancer therapy resistance
2023 · Deborah R. Caswell, Philippe Gui, et al. · Nature Genetics · 107
PDF
Neoadjuvant Osimertinib for the Treatment of Stage I-IIIA Epidermal Growth Factor Receptor–Mutated Non–Small Cell Lung Cancer: A Phase II Multicenter Study
2024 · Collin M. Blakely, Anatoly Urisman, et al. · Journal of Clinical Oncology · 77
Mixed responses to targeted therapy driven by chromosomal instability through p53 dysfunction and genome doubling
2024 · Sebastijan Hobor, Maise Al Bakir, et al. · Nature Communications · 52
PDF
Checkpoint Inhibitor Immunotherapy to Treat Temozolomide-Associated Hypermutation in Advanced Atypical Carcinoid Tumor of the Lung
2022 · Fangdi Sun, James P. Grenert, et al. · JCO Precision Oncology · 14
Heterogeneity and targeted therapy-induced adaptations in lung cancer revealed by longitudinal single-cell RNA sequencing
2019 · Ashley Maynard, Caroline E. McCoach, et al. · bioRxiv (Cold Spring Harbor Laboratory) · 11
PDF
A phase I/Ib study of the aurora kinase A inhibitor alisertib in combination with osimertinib in advanced osimertinib-resistant EGFR-mutated lung cancer.
2024 · Turja Chakrabarti, Greg M. Allen, et al. · Journal of Clinical Oncology · 7
CDK4 or CDK6 upregulation induces DNA replication stress and genomic instability to cause EGFR targeted therapy resistance in lung cancer
2024 · Beatrice Gini, Philippe Gui, et al. · bioRxiv (Cold Spring Harbor Laboratory) · 5
PDF
CDK4 or CDK6 upregulation induces DNA replication stress and genomic instability to cause EGFR targeted therapy resistance in lung cancer
2026 · Beatrice Gini, Philippe Gui, et al. · eLife
PDF
CDK4 or CDK6 upregulation induces DNA replication stress and genomic instability to cause EGFR targeted therapy resistance in lung cancer
2026 · Beatrice Gini, Philippe Gui, et al. · eLife
PDF
Abstract 2197: Targeted cancer therapy induces APOBEC fueling the evolution of drug resistance
2022 · Manasi Mayekar, Deborah Caswell, et al. · Cancer Research
Abstract LB124: APOBEC3B fuels evolution of resistance during targeted cancer therapy
2021 · Manasi K. Mayekar, Deborah Caswell, et al. · Cancer Research
Works count: 12
Citation count: 967
H-index: 7
I10-index: 6
Year
Topic
Type